 | Related Articles |
[Antiepileptic drugs].
Rev Neurol. 2018 06 05;66(s02):S21-S25
Authors: Herranz JL
Abstract
We report the most notable pharmacokinetic and pharmacodynamic characteristics of the antiepileptic drugs commercialised in the last four years (eslicarbazepine acetate, brivaracetam and perampanel). Their efficacy and safety are analysed in open-label clinical trials, which are the ones that reproduce their use in everyday life, without the rigid protocols used in clinical trials.
PMID: 29876908 [PubMed - indexed for MEDLINE]
from A via a.sfakia on Inoreader http://bit.ly/2sMBpn5
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,